# Physical activity promotion in the primary care setting in pre- and type 2 diabetes - the Sophia step study, an RCT

**Authors:** Jenny Rossen, Agneta Yngve, Maria Hagströmer, Kerstin Brismar, Barbara E. Ainsworth, Christina Iskull, Peter Möller, Unn-Britt Johansson

PMC · DOI: 10.1186/s12889-015-1941-9 · BMC Public Health · 2015-07-12

## TL;DR

This study tests if a multi-component physical activity program improves health outcomes more than a basic pedometer program in people with pre- or type 2 diabetes.

## Contribution

The study introduces and evaluates a multi-component physical activity intervention in diabetes care.

## Key findings

- The multi-component intervention includes pedometers, motivational support, and group consultations.
- The study will assess effects on HbA1c, cardiovascular risk factors, and overall health over 24 months.

## Abstract

Physical activity prevents or delays progression of impaired glucose tolerance in high-risk individuals. Physical activity promotion should serve as a basis in diabetes care. It is necessary to develop and evaluate health-promoting methods that are feasible as well as cost-effective within diabetes care. The aim of Sophia Step Study is to evaluate the impact of a multi-component and a single component physical activity intervention aiming at improving HbA1c (primary outcome) and other metabolic and cardiovascular risk factors, physical activity levels and overall health in patients with pre- and type 2 diabetes.

Sophia Step Study is a randomized controlled trial and participants are randomly assigned to either a multi-component intervention group (A), a pedometer group (B) or a control group (C). In total, 310 patients will be included and followed for 24 months. Group A participants are offered pedometers and a website to register steps, physical activity on prescription with yearly follow-ups, motivational interviewing (10 occasions) and group consultations (including walks, 12 occasions). Group B participants are offered pedometers and a website to register steps. Group C are offered usual care. The theoretical framework underpinning the interventions is the Health Belief Model, the Stages of Change Model, and the Social Cognitive Theory. Both the multi-component intervention (group A) and the pedometer intervention (group B) are using several techniques for behavior change such as self-monitoring, goal setting, feedback and relapse prevention.

Measurements are made at week 0, 8, 12, 16, month 6, 9, 12, 18 and 24, including metabolic and cardiovascular biomarkers (HbA1c as primary health outcome), accelerometry and daily steps. Furthermore, questionnaires were used to evaluate dietary intake, physical activity, perceived ability to perform physical activity, perceived support for being active, quality of life, anxiety, depression, well-being, perceived treatment, perceived stress and diabetes self- efficacy.

This study will show if a multi-component intervention using pedometers with group- and individual consultations is more effective than a single- component intervention using pedometers alone, in increasing physical activity and improving HbA1c, other metabolic and cardiovascular risk factors, physical activity levels and overall health in patients with pre- and type 2 diabetes.

ClinicalTrials.gov Identifier: NCT02374788. Registered 28 January 2015.

## Linked entities

- **Diseases:** type 2 diabetes (MONDO:0005148), pre-diabetes (MONDO:0006920)

## Full-text entities

- **Genes:** INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, APOA1 (apolipoprotein A1) [NCBI Gene 335] {aka AMYLD3, HPALP2, apo(a)}, APOB (apolipoprotein B) [NCBI Gene 338] {aka FCHL2, FLDB, LDLCQ4, apoB-100, apoB-48}, IGFBP1 (insulin like growth factor binding protein 1) [NCBI Gene 3484] {aka AFBP, IBP1, IGF-BP25, PP12, hIGFBP-1}
- **Diseases:** tired (MESH:C537575), pain/ discomfort (MESH:D010146), hypoglycemia (MESH:D007003), difficulties falling asleep (MESH:C537863), ulcer (MESH:D014456), peripheral neuropathy (MESH:D010523), type 2 diabetes (MESH:D003924), bad mood (MESH:D019964), Diabetes (MESH:D003920), premature death (MESH:D003643), CVD (MESH:D002318), Myocardial infarction (MESH:D009203), impaired glucose tolerance (MESH:D018149), Anxiety and Depression (MESH:D001007), diabetic foot ulcer (MESH:D017719), Depression (MESH:D003866), pre (MESH:D058246), FaR (MESH:D019966),  (MESH:D011236)
- **Chemicals:** Cholesterol (MESH:D002784), creatinine (MESH:D003404), blood glucose (MESH:D001786), lipid (MESH:D008055), Free fatty acids (MESH:D005230), alcohol (MESH:D000438), glucose (MESH:D005947), Triglycerides (MESH:D014280), FaR. (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4499440/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4499440/full.md

## References

60 references — full list in the complete paper: https://tomesphere.com/paper/PMC4499440/full.md

---
Source: https://tomesphere.com/paper/PMC4499440